These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22182928)

  • 1. Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
    Cappoen D; Jacobs J; Nguyen Van T; Claessens S; Diels G; Anthonissen R; Einarsdottir T; Fauville M; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2012 Feb; 48():57-68. PubMed ID: 22182928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.
    Nagesh HN; Suresh N; Mahalakshmi Naidu K; Arun B; Padma Sridevi J; Sriram D; Yogeeswari P; Chandra Sekhar KV
    Eur J Med Chem; 2014 Mar; 74():333-9. PubMed ID: 24486416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
    Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
    Cappoen D; Torfs E; Meiresonne T; Claes P; Semina E; Holvoet F; de Macedo MB; Cools F; Piller T; Matheeussen A; Van Calster K; Caljon G; Delputte P; Maes L; Neyrolles O; De Kimpe N; Mangelinckx S; Cos P
    Eur J Med Chem; 2019 Nov; 181():111549. PubMed ID: 31376569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,4-diarylpiperazines and analogs as anti-tubercular agents: synthesis and biological evaluation.
    Forge D; Cappoen D; Laurent J; Stanicki D; Mayence A; Huang TL; Verschaeve L; Huygen K; Vanden Eynde JJ
    Eur J Med Chem; 2012 Mar; 49():95-101. PubMed ID: 22301215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
    Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
    Cappoen D; Forge D; Vercammen F; Mathys V; Kiass M; Roupie V; Anthonissen R; Verschaeve L; Vanden Eynde JJ; Huygen K
    Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
    Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
    Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes.
    Giovagnoli S; Marenzoni ML; Nocchetti M; Santi C; Blasi P; Schoubben A; Ricci M
    J Pharm Pharmacol; 2014 Jan; 66(1):106-21. PubMed ID: 24341950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
    Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of novel iron compounds as potential therapeutic agents against tuberculosis.
    Tarallo MB; Urquiola C; Monge A; Costa BP; Ribeiro RR; Costa-Filho AJ; Mercader RC; Pavan FR; Leite CQ; Torre MH; Gambino D
    J Inorg Biochem; 2010 Nov; 104(11):1164-70. PubMed ID: 20701975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
    Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
    Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
    Dobrikov GM; Valcheva V; Stoilova-Disheva M; Momekov G; Tzvetkova P; Chimov A; Dimitrov V
    Eur J Med Chem; 2012 Feb; 48():45-56. PubMed ID: 22154833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
    Kamal A; Shetti RV; Azeeza S; Ahmed SK; Swapna P; Reddy AM; Khan IA; Sharma S; Abdullah ST
    Eur J Med Chem; 2010 Oct; 45(10):4545-53. PubMed ID: 20705368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.